Inhibition of Caspase-11-Mediated Pyroptosis Alleviates Acute Kidney Injury Associated with Severe Acute Pancreatitis

Yang Shao1,2, Chang Li2, Yingjian Jiang2

  • 1Qingdao Medical College, Qingdao University, Qingdao, Shandong Province, China.

Insights

Caspase-11-mediated pyroptosis contributes to acute kidney injury (AKI) in severe acute pancreatitis (SAP). Inhibiting this process with wedelolactone improved kidney function and reduced inflammation in a rat model, suggesting a new treatment strategy.

Area of Science:

  • Nephrology
  • Gastroenterology
  • Immunology

Background:

  • Acute kidney injury (AKI) frequently complicates severe acute pancreatitis (SAP).
  • The role of caspase-11-mediated pyroptosis in SAP-induced AKI is not well understood.
  • Pyroptosis is a key inflammatory cell death pathway implicated in various diseases.

Purpose of the Study:

  • To investigate the involvement of caspase-11-mediated pyroptosis in SAP-induced AKI.
  • To determine if inhibiting caspase-11-mediated pyroptosis can ameliorate SAP-induced AKI.
  • To explore potential therapeutic targets for SAP-induced AKI.

Main Methods:

  • A rat model of SAP-induced AKI was established using sodium taurocholate.
  • Wedelolactone, a caspase-11 inhibitor, was administered at 1 and 6 hours post-SAP induction.
  • Serum markers (amylase, lipase, IL-6, BUN, TNF-α, Cr), pyroptosis proteins (caspase-11, GSDMD), and cytokines (IL-1β, IL-18) were measured.
  • Histopathological analysis of pancreas and kidney tissues was performed.

Main Results:

  • SAP induction significantly elevated serum biochemical markers and pyroptosis-related proteins in kidney tissues.
  • Wedelolactone treatment reduced pyroptosis markers, inflammatory cytokines, and serum levels of lipase, amylase, IL-6, TNF-α, BUN, and Cr.
  • Histopathological examination revealed amelioration of renal and pancreatic damage in wedelolactone-treated rats.

Conclusions:

  • Caspase-11-mediated pyroptosis plays a significant role in the pathogenesis of SAP-induced AKI.
  • Inhibition of caspase-11-mediated pyroptosis demonstrates therapeutic potential for SAP-induced AKI.
  • Targeting caspase-11 offers a promising novel treatment strategy for this condition.

Related Concept Videos

Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
458
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
167
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
53
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
59
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
34